Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 461

1.

Post-transplant Monoclonal Gammopathy of Renal Significance: A Case Series.

Rana R, Cockwell P, Pratt G, Cook M, Drayson M, Vydianath B, Neil D, Pinney JH.

Transplant Proc. 2020 Mar 3. pii: S0041-1345(19)30914-5. doi: 10.1016/j.transproceed.2019.12.040. [Epub ahead of print]

PMID:
32143865
2.

Empowering Voice through the Creation of a Safe space: An experience of Aboriginal Women in Regional Queensland.

M Bernardes C, C Valery P, Arley B, Pratt G, Medlin L, Meiklejohn JA.

Int J Environ Res Public Health. 2020 Feb 25;17(5). pii: E1476. doi: 10.3390/ijerph17051476.

3.

Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians.

Valery PC, Clark PJ, Pratt G, Bernardes CM, Hartel G, Toombs M, Irvine KM, Powell EE.

Int J Equity Health. 2020 Feb 17;19(1):27. doi: 10.1186/s12939-020-1144-6.

4.

Levofloxacin prophylaxis in patients with myeloma - Authors' reply.

Drayson MT, Bowcock S, Planche T, Iqbal G, Pratt G, Yong K, Dunn JA.

Lancet Oncol. 2020 Feb;21(2):e69. doi: 10.1016/S1470-2045(20)30020-6. No abstract available.

PMID:
32007200
5.

Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients with Rheumatoid Arthritis Worldwide: An OMERACT Systematic Review.

Lopez-Olivo MA, Zogala RJ, des Bordes J, Zamora NV, Christensen R, Rai D, Goel N, Carmona L, Pratt G, Strand V, Suarez-Almazor ME.

Arthritis Care Res (Hoboken). 2020 Jan 31. doi: 10.1002/acr.24163. [Epub ahead of print]

PMID:
32004421
6.

Low dose Btk inhibitors selectively block platelet activation by CLEC-2.

Nicolson PLR, Nock SH, Hinds J, Garcia-Quintanilla L, Smith CW, Campos J, Brill A, Pike JA, Khan AO, Poulter NS, Kavanagh DM, Watson S, Watson CN, Clifford H, Huissoon AP, Pollitt AY, Eble JA, Pratt G, Watson SP, Hughes CE.

Haematologica. 2020 Jan 16. pii: haematol.2019.218545. doi: 10.3324/haematol.2019.218545. [Epub ahead of print]

7.

Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies.

des Bordes J, Prasad S, Pratt G, Suarez-Almazor ME, Lopez-Olivo MA.

PLoS One. 2020 Jan 15;15(1):e0227765. doi: 10.1371/journal.pone.0227765. eCollection 2020.

8.

Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia.

Parry HM, Mirajkar N, Cutmore N, Zuo J, Long H, Kwok M, Oldrieve C, Hudson C, Stankovic T, Paneesha S, Kelly M, Begum J, McSkeane T, Pratt G, Moss P.

Front Immunol. 2019 Dec 12;10:2832. doi: 10.3389/fimmu.2019.02832. eCollection 2019.

9.

Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL.

Kwok M, Oldreive C, Rawstron AC, Goel A, Papatzikas G, Jones RE, Drennan S, Agathanggelou A, Sharma-Oates A, Evans P, Smith E, Dalal S, Mao J, Hollows R, Gordon N, Hamada M, Davies NJ, Parry H, Beggs AD, Munir T, Moreton P, Paneesha S, Pratt G, Taylor AMR, Forconi F, Baird DM, Cazier JB, Moss P, Hillmen P, Stankovic T.

Blood. 2020 Feb 6;135(6):411-428. doi: 10.1182/blood.2019001262.

PMID:
31794600
10.

Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.

Drayson MT, Bowcock S, Planche T, Iqbal G, Pratt G, Yong K, Wood J, Raynes K, Higgins H, Dawkins B, Meads D, Hulme CT, Whittaker AC, Hawkey P, Low E, Dunn JA.

Health Technol Assess. 2019 Nov;23(62):1-94. doi: 10.3310/hta23620.

11.

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.

Drayson MT, Bowcock S, Planche T, Iqbal G, Pratt G, Yong K, Wood J, Raynes K, Higgins H, Dawkins B, Meads D, Hulme CT, Monahan I, Karunanithi K, Dignum H, Belsham E, Neilson J, Harrison B, Lokare A, Campbell G, Hamblin M, Hawkey P, Whittaker AC, Low E, Dunn JA; TEAMM Trial Management Group and Trial Investigators.

Lancet Oncol. 2019 Dec;20(12):1760-1772. doi: 10.1016/S1470-2045(19)30506-6. Epub 2019 Oct 23.

12.

Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels.

Heaney JLJ, Richter A, Bowcock S, Pratt G, Child JA, Jackson G, Morgan G, Turesson I, Drayson MT.

Haematologica. 2020 Apr;105(4):e169-e171. doi: 10.3324/haematol.2019.224360. Epub 2019 Aug 8. No abstract available.

13.

Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.

Nador G, Ramasamy K, Panitsas F, Pratt G, Sadler R, Javaid MK.

Rheumatology (Oxford). 2019 Jul 1;58(7):1142-1153. doi: 10.1093/rheumatology/kez127. Review.

PMID:
31225884
14.

'We just don't talk about it': Aboriginal and Torres Strait Islander peoples' perceptions of cancer in regional Queensland.

Meiklejohn JA, Arley BD, Pratt G, Valery PC, Bernardes CM.

Rural Remote Health. 2019 May;19(2):4789. doi: 10.22605/RRH4789. Epub 2019 May 29.

15.

Correspondence on: A rare complication of bone marrow aspiration and trephine biopsy: Staphylococcus aureus osteomyelitis and septicaemia - response to Eades & Bapat.

Khakwani M, Pratt G, David M.

Br J Haematol. 2019 Jul;186(2):384. doi: 10.1111/bjh.15930. Epub 2019 Apr 24. No abstract available.

PMID:
31020652
16.

Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers.

Murray J, Pratt G, Jacob A, Clark F, Blundred R, Fox S, Bishop R, Wheatley K, Khanim F, Bunce C, Drayson M.

Contemp Clin Trials Commun. 2019 Apr 10;14:100361. doi: 10.1016/j.conctc.2019.100361. eCollection 2019 Jun.

17.

Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.

Ahmedzai SH, Snowden JA, Ashcroft AJ, Cairns DA, Williams C, Hockaday A, Cavenagh JD, Ademokun D, Tholouli E, Allotey D, Dhanapal V, Jenner M, Yong K, Cavet J, Hunter H, Bird JM, Pratt G, Parrish C, Brown JM, Morris TCM, Cook G; National Cancer Research Institute Haemato-Oncology Clinical Studies Group.

J Clin Oncol. 2019 Jul 1;37(19):1617-1628. doi: 10.1200/JCO.18.01006. Epub 2019 Apr 10.

18.

Allele-specific binding of RNA-binding proteins reveals functional genetic variants in the RNA.

Yang EW, Bahn JH, Hsiao EY, Tan BX, Sun Y, Fu T, Zhou B, Van Nostrand EL, Pratt GA, Freese P, Wei X, Quinones-Valdez G, Urban AE, Graveley BR, Burge CB, Yeo GW, Xiao X.

Nat Commun. 2019 Mar 22;10(1):1338. doi: 10.1038/s41467-019-09292-w.

19.

Collagenase Management of Multicord Dupuytren's Disease under Intravenous Sedation: A Prospective Cohort Study.

Wiseman J, Tree K, Guio-Aguilar P, Pratt G, Nizzaro D, Leung M, Leong J.

Plast Reconstr Surg Glob Open. 2019 Feb 20;7(2):e2133. doi: 10.1097/GOX.0000000000002133. eCollection 2019 Feb.

20.

Systematic Review of Recommendations on the Use of Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Cancer.

Lopez-Olivo MA, Colmegna I, Karpes Matusevich AR, Qi SR, Zamora NV, Sharma R, Pratt G, Suarez-Almazor ME.

Arthritis Care Res (Hoboken). 2020 Mar;72(3):309-318. doi: 10.1002/acr.23865.

PMID:
30821928
21.

Phase I Trial of Inducible Caspase 9 T Cells in Adult Stem Cell Transplant Demonstrates Massive Clonotypic Proliferative Potential and Long-term Persistence of Transgenic T Cells.

Zhang P, Raju J, Ullah MA, Au R, Varelias A, Gartlan KH, Olver SD, Samson LD, Sturgeon E, Zomerdijk N, Avery J, Gargett T, Brown MP, Coin LJ, Ganesamoorthy D, Hutchins C, Pratt GR, Kennedy GA, Morton AJ, Curley CI, Hill GR, Tey SK.

Clin Cancer Res. 2019 Mar 15;25(6):1749-1755. doi: 10.1158/1078-0432.CCR-18-3069. Epub 2019 Feb 14.

22.

The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.

Cook G, Royle KL, O'Connor S, Cairns DA, Ashcroft AJ, Williams CD, Hockaday A, Cavenagh JD, Snowden JA, Ademokun D, Tholouli E, Andrews VE, Jenner M, Parrish C, Yong K, Cavet J, Hunter H, Bird JM, Pratt G, Drayson MT, Brown JM, Morris TCM; National Cancer Research Institute Haemato-oncology Clinical Studies Group.

Br J Haematol. 2019 May;185(3):450-467. doi: 10.1111/bjh.15782. Epub 2019 Feb 6.

23.

Regulation of RNA editing by RNA-binding proteins in human cells.

Quinones-Valdez G, Tran SS, Jun HI, Bahn JH, Yang EW, Zhan L, Brümmer A, Wei X, Van Nostrand EL, Pratt GA, Yeo GW, Graveley BR, Xiao X.

Commun Biol. 2019 Jan 14;2:19. doi: 10.1038/s42003-018-0271-8. eCollection 2019.

24.

PALB2 variant status in hematological malignancies - a potential therapeutic target?

Oldreive CE, Byrd PJ, Stewart GS, Taylor AJ, Farhat S, Skowronska A, Smith E, Raghavan M, Janic D, Dokmanovic L, Clokie S, Davies N, Kwok M, Pratt G, Paneesha S, Moss P, Stankovic T, Taylor M.

Leuk Lymphoma. 2019 Jul;60(7):1823-1826. doi: 10.1080/10428194.2018.1551539. Epub 2019 Jan 7. No abstract available.

PMID:
30614742
25.

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.

Went M, Sud A, Speedy H, Sunter NJ, Försti A, Law PJ, Johnson DC, Mirabella F, Holroyd A, Li N, Orlando G, Weinhold N, van Duin M, Chen B, Mitchell JS, Mansouri L, Juliusson G, Smedby KE, Jayne S, Majid A, Dearden C, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Rosenquist R, Kuiper R, Stephens OW, Bertsch U, Broderick P, Einsele H, Gregory WM, Hillengass J, Hoffmann P, Jackson GH, Jöckel KH, Nickel J, Nöthen MM, da Silva Filho MI, Thomsen H, Walker BA, Broyl A, Davies FE, Hansson M, Goldschmidt H, Dyer MJS, Kaiser M, Sonneveld P, Morgan GJ, Hemminki K, Nilsson B, Catovsky D, Allan JM, Houlston RS.

Blood Cancer J. 2018 Dec 21;9(1):1. doi: 10.1038/s41408-018-0162-8.

26.

Widespread RNA editing dysregulation in brains from autistic individuals.

Tran SS, Jun HI, Bahn JH, Azghadi A, Ramaswami G, Van Nostrand EL, Nguyen TB, Hsiao YE, Lee C, Pratt GA, Martínez-Cerdeño V, Hagerman RJ, Yeo GW, Geschwind DH, Xiao X.

Nat Neurosci. 2019 Jan;22(1):25-36. doi: 10.1038/s41593-018-0287-x. Epub 2018 Dec 17.

27.

Fatal systemic angiomatosis with widespread sclerotic skeletal changes, diagnosed with the aid of a bone marrow biopsy: the lymphatics enter the bone marrow.

Rudzki Z, Lovell R, Miller B, Murthy V, Paneesha S, Pratt G, Smith N.

Pol J Pathol. 2018;69(3):314-318. doi: 10.5114/pjp.2018.79552.

28.

Cerebral Blood Flow in Polytrauma: Transcranial Doppler Analysis in a Nonhuman Primate Shock Model.

Pratt GA 3rd, Hathaway EN, Hemond PJ, Tadaki DK, Sheppard FR, Glaser JJ.

J Surg Res. 2018 Dec;232:146-153. doi: 10.1016/j.jss.2018.05.062. Epub 2018 Jul 5.

PMID:
30463710
29.

RBP-Maps enables robust generation of splicing regulatory maps.

Yee BA, Pratt GA, Graveley BR, Van Nostrand EL, Yeo GW.

RNA. 2019 Feb;25(2):193-204. doi: 10.1261/rna.069237.118. Epub 2018 Nov 9.

30.

A rare complication of bone marrow aspiration and trephine biopsy: Staphylococcus aureus osteomyelitis and septicaemia.

Khakwani M, Srinath S, Pratt G, Moss P.

Br J Haematol. 2019 Jan;184(1):7. doi: 10.1111/bjh.15630. Epub 2018 Nov 8. No abstract available.

PMID:
30408144
31.

Successful Renal Outcome in Membranoproliferative Glomerulonephritis Following Treatment of the Underlying Subtle Clone: A Case Report.

Rana R, Cockwell P, Vydianath B, Cook M, Pratt G, Drayson MT, Pinney JH.

Mayo Clin Proc Innov Qual Outcomes. 2018 Jun 5;2(3):297-302. doi: 10.1016/j.mayocpiqo.2018.04.003. eCollection 2018 Sep.

32.

RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.

Chapman MA, Sive J, Ambrose J, Roddie C, Counsell N, Lach A, Abbasian M, Popat R, Cavenagh JD, Oakervee H, Streetly MJ, Schey S, Koh M, Willis F, Virchis AE, Crowe J, Quinn MF, Cook G, Crawley CR, Pratt G, Cook M, Braganza N, Adedayo T, Smith P, Clifton-Hadley L, Owen RG, Sonneveld P, Keats JJ, Herrero J, Yong K.

Blood. 2018 Nov 15;132(20):2154-2165. doi: 10.1182/blood-2018-05-849893. Epub 2018 Sep 4.

33.

National survey of imaging practice for suspected or confirmed plasma cell malignancies.

Westerland OA, Pratt G, Kazmi M, El-Najjar I, Streetly M, Yong K, Morris M, Mehan R, Sambrook M, Hall-Craggs M, Silver D, Goh V.

Br J Radiol. 2018 Dec;91(1092):20180462. doi: 10.1259/bjr.20180462. Epub 2018 Nov 1.

34.

Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI.

Nicolson PLR, Hughes CE, Watson S, Nock SH, Hardy AT, Watson CN, Montague SJ, Clifford H, Huissoon AP, Malcor JD, Thomas MR, Pollitt AY, Tomlinson MG, Pratt G, Watson SP.

Haematologica. 2018 Dec;103(12):2097-2108. doi: 10.3324/haematol.2018.193391. Epub 2018 Jul 19.

35.

Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies.

Yap A, Lopez-Olivo MA, Dubowitz J, Pratt G, Hiller J, Gottumukkala V, Sloan E, Riedel B, Schier R.

Br J Anaesth. 2018 Jul;121(1):45-57. doi: 10.1016/j.bja.2018.03.024. Epub 2018 May 3.

36.

Sequence, Structure, and Context Preferences of Human RNA Binding Proteins.

Dominguez D, Freese P, Alexis MS, Su A, Hochman M, Palden T, Bazile C, Lambert NJ, Van Nostrand EL, Pratt GA, Yeo GW, Graveley BR, Burge CB.

Mol Cell. 2018 Jun 7;70(5):854-867.e9. doi: 10.1016/j.molcel.2018.05.001. Epub 2018 Jun 7.

37.

A competitive lateral flow assay for the detection of tenofovir.

Pratt GW, Fan A, Melakeberhan B, Klapperich CM.

Anal Chim Acta. 2018 Aug 9;1017:34-40. doi: 10.1016/j.aca.2018.02.039. Epub 2018 Feb 20.

38.

Acute lumbar paraspinal compartment syndrome: a systematic review.

Alexander W, Low N, Pratt G.

ANZ J Surg. 2018 Sep;88(9):854-859. doi: 10.1111/ans.14342. Epub 2018 Jan 8.

PMID:
29316189
39.

Erratum to: Robust, Cost-Effective Profiling of RNA Binding Protein Targets with Single-end Enhanced Crosslinking and Immunoprecipitation (seCLIP).

Van Nostrand EL, Nguyen TB, Gelboin-Burkhart C, Wang R, Blue SM, Pratt GA, Louie AL, Yeo GW.

Methods Mol Biol. 2017;1648:E1. doi: 10.1007/978-1-4939-7204-3_19. No abstract available.

PMID:
29230720
40.

Analysis of polycyclic aromatic hydrocarbons (PAHs) in air using passive sampling calibrated with active measurements.

Ellickson KM, McMahon CM, Herbrandson C, Krause MJ, Schmitt CM, Lippert CJ, Pratt GC.

Environ Pollut. 2017 Dec;231(Pt 1):487-496. doi: 10.1016/j.envpol.2017.08.049. Epub 2017 Aug 29.

PMID:
28841501
41.

Variation in single-nucleotide sensitivity of eCLIP derived from reverse transcription conditions.

Van Nostrand EL, Shishkin AA, Pratt GA, Nguyen TB, Yeo GW.

Methods. 2017 Aug 15;126:29-37. doi: 10.1016/j.ymeth.2017.08.002. Epub 2017 Aug 5.

42.

Robust, Cost-Effective Profiling of RNA Binding Protein Targets with Single-end Enhanced Crosslinking and Immunoprecipitation (seCLIP).

Van Nostrand EL, Nguyen TB, Gelboin-Burkhart C, Wang R, Blue SM, Pratt GA, Louie AL, Yeo GW.

Methods Mol Biol. 2017;1648:177-200. doi: 10.1007/978-1-4939-7204-3_14. Erratum in: Methods Mol Biol. 2017;1648:E1.

43.

Guidelines for the use of imaging in the management of patients with myeloma.

Chantry A, Kazmi M, Barrington S, Goh V, Mulholland N, Streetly M, Lai M, Pratt G; British Society for Haematology Guidelines.

Br J Haematol. 2017 Aug;178(3):380-393. doi: 10.1111/bjh.14827. Epub 2017 Jul 5.

PMID:
28677897
44.

Increased fracture risk in plasma cell dyscrasias is associated with poorer overall survival.

McIlroy G, Mytton J, Evison F, Yadav P, Drayson MT, Cook M, Pratt G, Cockwell P, Pinney JH.

Br J Haematol. 2017 Oct;179(1):61-65. doi: 10.1111/bjh.14815. Epub 2017 Jun 27.

PMID:
28653323
45.

A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma.

Pratt G, Yap C, Oldreive C, Slade D, Bishop R, Griffiths M, Dyer MJS, Fegan C, Oscier D, Pettitt A, Matutes E, Devereux S, Allsup D, Bloor A, Hillmen P, Follows G, Rule S, Moss P, Stankovic T.

Br J Haematol. 2018 Aug;182(3):429-433. doi: 10.1111/bjh.14793. Epub 2017 Jun 23. No abstract available.

PMID:
28643365
46.

Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts.

Davies NJ, Kwok M, Gould C, Oldreive CE, Mao J, Parry H, Smith E, Agathanggelou A, Pratt G, Taylor AMR, Moss P, Griffiths M, Stankovic T.

Oncotarget. 2017 Jul 4;8(27):44749-44760. doi: 10.18632/oncotarget.17432.

47.

USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status.

Agathanggelou A, Smith E, Davies NJ, Kwok M, Zlatanou A, Oldreive CE, Mao J, Da Costa D, Yadollahi S, Perry T, Kearns P, Skowronska A, Yates E, Parry H, Hillmen P, Reverdy C, Delansorne R, Paneesha S, Pratt G, Moss P, Taylor AMR, Stewart GS, Stankovic T.

Blood. 2017 Jul 13;130(2):156-166. doi: 10.1182/blood-2016-12-758219. Epub 2017 May 11.

PMID:
28495793
48.

Neoplastic plasma cells generate an inflammatory environment within bone marrow and markedly alter the distribution of T cells between lymphoid compartments.

Goodyear OC, Essex S, Seetharam A, Basu S, Moss P, Pratt G.

Oncotarget. 2017 May 2;8(18):30383-30394. doi: 10.18632/oncotarget.16628.

49.

Telomere length is a critical determinant for survival in multiple myeloma.

Hyatt S, Jones RE, Heppel NH, Grimstead JW, Fegan C, Jackson GH, Hills R, Allan JM, Pratt G, Pepper C, Baird DM.

Br J Haematol. 2017 Jul;178(1):94-98. doi: 10.1111/bjh.14643. Epub 2017 Mar 24.

PMID:
28342200
50.

Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis.

Pan X, Lopez-Olivo MA, Song J, Pratt G, Suarez-Almazor ME.

BMJ Open. 2017 Mar 1;7(3):e013242. doi: 10.1136/bmjopen-2016-013242. Review.

Supplemental Content

Support Center